Development of the Commercial Manufacturing Process for Ipatasertib
Ipatasertib is a potent small molecule Akt kinase inhibitor currently being tested in Phase III clinical trials for the treatment of metastatic castration-resistant prostate cancer and triple negative metastatic breast cancer. In this paper an overview of the development achievements towards the com...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Swiss Chemical Society
2021-08-01
|
| Series: | CHIMIA |
| Subjects: |